M
Muhammad Akram
Publications - 1
Citations - 494
Muhammad Akram is an academic researcher. The author has contributed to research in topics: Neutropenia & Progressive disease. The author has an hindex of 1, co-authored 1 publications receiving 28 citations.
Papers
More filters
Journal ArticleDOI
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Jesus G. Berdeja,Deepu Madduri,Saad Z. Usmani,Andrzej Jakubowiak,Mounzer Agha,Adam D. Cohen,A. Keith Stewart,Parameswaran Hari,Myo Htut,Alexander M. Lesokhin,Abhinav Deol,Nikhil C. Munshi,Elizabeth O'Donnell,David Avigan,Indrajeet Singh,Enrique Zudaire,Tzu-Min Yeh,Alicia J. Allred,Yunsi Olyslager,Arnob Banerjee,Carolyn C. Jackson,Jenna D. Goldberg,Jordan M. Schecter,William Deraedt,Sen Hong Zhuang,Jeffrey R. Infante,Dong Geng,Xiaoling Wu,Marlene J Carrasco-Alfonso,Muhammad Akram,Farah Hossain,Syed Rizvi,Frank Fan,Yi Lin,Thomas Martin,Sundar Jagannath +35 more
TL;DR: The CARITUDE-1 trial as discussed by the authors evaluated the safety and clinical activity of ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor T-cell therapy with two B-cell maturation antigen-targeting single-domain antibodies.